1. Home
  2. WRAP vs AVTX Comparison

WRAP vs AVTX Comparison

Compare WRAP & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRAP
  • AVTX
  • Stock Information
  • Founded
  • WRAP 2016
  • AVTX 2011
  • Country
  • WRAP United States
  • AVTX United States
  • Employees
  • WRAP N/A
  • AVTX N/A
  • Industry
  • WRAP Ordnance And Accessories
  • AVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WRAP Industrials
  • AVTX Health Care
  • Exchange
  • WRAP Nasdaq
  • AVTX Nasdaq
  • Market Cap
  • WRAP 91.2M
  • AVTX 88.4M
  • IPO Year
  • WRAP N/A
  • AVTX 2015
  • Fundamental
  • Price
  • WRAP $1.98
  • AVTX $8.18
  • Analyst Decision
  • WRAP
  • AVTX Strong Buy
  • Analyst Count
  • WRAP 0
  • AVTX 4
  • Target Price
  • WRAP N/A
  • AVTX $33.00
  • AVG Volume (30 Days)
  • WRAP 156.8K
  • AVTX 65.8K
  • Earning Date
  • WRAP 11-14-2024
  • AVTX 03-28-2025
  • Dividend Yield
  • WRAP N/A
  • AVTX N/A
  • EPS Growth
  • WRAP N/A
  • AVTX N/A
  • EPS
  • WRAP N/A
  • AVTX N/A
  • Revenue
  • WRAP $4,231,000.00
  • AVTX $820,000.00
  • Revenue This Year
  • WRAP N/A
  • AVTX N/A
  • Revenue Next Year
  • WRAP N/A
  • AVTX N/A
  • P/E Ratio
  • WRAP N/A
  • AVTX N/A
  • Revenue Growth
  • WRAP N/A
  • AVTX N/A
  • 52 Week Low
  • WRAP $1.21
  • AVTX $4.17
  • 52 Week High
  • WRAP $4.68
  • AVTX $34.46
  • Technical
  • Relative Strength Index (RSI)
  • WRAP 51.68
  • AVTX 52.50
  • Support Level
  • WRAP $1.92
  • AVTX $7.82
  • Resistance Level
  • WRAP $2.09
  • AVTX $8.50
  • Average True Range (ATR)
  • WRAP 0.14
  • AVTX 0.78
  • MACD
  • WRAP -0.02
  • AVTX 0.20
  • Stochastic Oscillator
  • WRAP 23.33
  • AVTX 73.11

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: